This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2009-2010.
Location History:
- Sandwich, GB (2009)
- Kalamazoo, MI (US) (2010)
Company Filing History:
Years Active: 2009-2010
Title: Mark Roger Cox: Innovator in Pharmaceutical Chemistry
Introduction
Mark Roger Cox is a distinguished inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of innovative compounds that have practical applications in medicine.
Latest Patents
Among his latest inventions are a range of alpha substituted 2-benzyl substituted imidazole compounds. These compounds, along with their pharmaceutically acceptable salts and solvates, are designed for use as parasiticides. The patents detail not only the synthesis processes for these compounds but also their potential applications in treating parasitic infections.
Career Highlights
Mark Roger Cox is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer has allowed him to work on groundbreaking research and development projects that aim to improve health outcomes through innovative drug solutions.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Jerome Sebastien Dauvergne and Christelle Lauret. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical solutions.
Conclusion
Mark Roger Cox's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patents and collaborative efforts continue to pave the way for advancements in the treatment of parasitic diseases.